These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 32049830)

  • 1. Venous thromboembolism prophylaxis in patients hospitalized in medical wards: A real life experience.
    Mahlab-Guri K; Otman MS; Replianski N; Rosenberg-Bezalel S; Rabinovich I; Sthoeger Z
    Medicine (Baltimore); 2020 Feb; 99(7):e19127. PubMed ID: 32049830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rate and predictors of thromboprophylaxis in internal medicine wards: Results from the AURELIO study.
    Magna A; Maggio E; Vidili G; Sciacqua A; Cogliati C; Di Giulio R; Bernardini S; Fallarino A; Palumbo IM; Pannunzio A; Bagnato C; Serra C; Boddi M; Falsetti L; Zaccone V; Ettorre E; Desideri G; Santoro L; Cantisani V; Pignatelli P; Santoliquido A; Violi F; Loffredo L;
    Thromb Res; 2024 Nov; 243():109148. PubMed ID: 39326194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A retrospective review of the use of thromboprophylaxis in patients who subsequently developed a venous thromboembolism after discharge from hospital.
    Wiseman DN; Harrison J
    N Z Med J; 2010 Feb; 123(1309):37-49. PubMed ID: 20186241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism.
    Kahn SR; Morrison DR; Diendéré G; Piché A; Filion KB; Klil-Drori AJ; Douketis JD; Emed J; Roussin A; Tagalakis V; Morris M; Geerts W
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD008201. PubMed ID: 29687454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended thromboprophylaxis in the acutely ill medical patient after hospitalization - a paradigm shift in post-discharge thromboprophylaxis.
    Mahan CE; Burnett AE; Fletcher ML; Spyropoulos AC
    Hosp Pract (1995); 2018 Feb; 46(1):5-15. PubMed ID: 29171776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venous thromboembolism risk assessment and prophylaxis in hospitalised medical patients in the Cape Town metropole, South Africa.
    Wehmeyer A; Coetzee R; McCartney J
    S Afr Med J; 2022 Feb; 112(2):13506. PubMed ID: 35139994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventions for implementation of thromboprophylaxis in hospitalized medical and surgical patients at risk for venous thromboembolism.
    Kahn SR; Morrison DR; Cohen JM; Emed J; Tagalakis V; Roussin A; Geerts W
    Cochrane Database Syst Rev; 2013 Jul; (7):CD008201. PubMed ID: 23861035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of venous thromboembolism and adequacy of thromboprophylaxis in 2380 acutely-ill hospitalized patients: Results from the PROFMiG cohort study.
    Ferreira BÁ; Danielian PLLB; Caetano GC; Ferreira CRL; de Oliveira MA; Colosimo EA; de Bastos M; Rezende SM
    Thromb Res; 2024 Nov; 243():109145. PubMed ID: 39244871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-life use of thromboprophylaxis in patients hospitalized for pulmonary disorders: A single-center retrospective study.
    Łukaszuk RF; Plens K; Undas A
    Adv Clin Exp Med; 2018 Feb; 27(2):237-243. PubMed ID: 29521068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.
    Barkoudah E; Piazza G; Hecht TEH; Grant P; Deitelzweig S; Fang MC; Fanikos J; Kao CK; Barnes GD; Chen T; Ramishvili T; Schnipper JL; Goldstein JN; Ruff CT; Kaatz S; Schwartz A; Connors JM; Goldhaber SZ
    Am J Med; 2020 May; 133 Suppl 1():1-27. PubMed ID: 32362349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical impact of application of risk assessment models (Padua Prediction Score and Improve Bleeding Score) on venous thromboembolism, major hemorrhage and health expenditure associated with pharmacologic VTE prophylaxis: a "real life" prospective and retrospective observational study on patients hospitalized in a Single Internal Medicine Unit (the STIME study).
    Depietri L; Marietta M; Scarlini S; Marcacci M; Corradini E; Pietrangelo A; Ventura P
    Intern Emerg Med; 2018 Jun; 13(4):527-534. PubMed ID: 29502330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors.
    Artifoni M; Danic G; Gautier G; Gicquel P; Boutoille D; Raffi F; Néel A; Lecomte R
    J Thromb Thrombolysis; 2020 Jul; 50(1):211-216. PubMed ID: 32451823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of venous thromboembolism (VTE) risk assessment and thrombo-prophylaxis practices in hospitalized medical and surgical patients at Aga Khan Hospital Dar es Salaam: single-centre retrospective study.
    Ismail A; Jadawji N; Adebayo P; Jusabani A; Hameed K; Zehri AA; Kiviri W; Ali A
    Pan Afr Med J; 2022; 42():160. PubMed ID: 36187041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective database analysis of the prevention of venous thromboembolism with low-molecular-weight heparin in acutely III medical inpatients in community practice.
    McGarry LJ; Thompson D
    Clin Ther; 2004 Mar; 26(3):419-30. PubMed ID: 15110135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of high-dose thromboprophylaxis in morbidly obese inpatients.
    Wang TF; Milligan PE; Wong CA; Deal EN; Thoelke MS; Gage BF
    Thromb Haemost; 2014 Jan; 111(1):88-93. PubMed ID: 24136071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended-duration thromboprophylaxis in acutely ill medical patients with recent reduced mobility: methodology for the EXCLAIM study.
    Hull RD; Schellong SM; Tapson VF; Monreal M; Samama MM; Turpie AG; Wildgoose P; Yusen RD
    J Thromb Thrombolysis; 2006 Aug; 22(1):31-8. PubMed ID: 16786230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of chemical thromboprophylaxis in critically ill medical and surgical patients with sepsis.
    Hanify JM; Dupree LH; Johnson DW; Ferreira JA
    J Crit Care; 2017 Feb; 37():206-210. PubMed ID: 27969572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for inpatient venous thromboembolism despite thromboprophylaxis.
    Wang TF; Wong CA; Milligan PE; Thoelke MS; Woeltje KF; Gage BF
    Thromb Res; 2014 Jan; 133(1):25-9. PubMed ID: 24300584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada.
    Kahn SR; Panju A; Geerts W; Pineo GF; Desjardins L; Turpie AG; Glezer S; Thabane L; Sebaldt RJ;
    Thromb Res; 2007; 119(2):145-55. PubMed ID: 16516275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended-duration betrixaban versus shorter-duration enoxaparin for venous thromboembolism prophylaxis in critically ill medical patients: an APEX trial substudy.
    Chi G; Gibson CM; Kalayci A; Cohen AT; Hernandez AF; Hull RD; Kahe F; Jafarizade M; Sharfaei S; Liu Y; Harrington RA; Goldhaber SZ
    Intensive Care Med; 2019 Apr; 45(4):477-487. PubMed ID: 30778649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.